Lack of evidence to support large-panel genomic testing in treatment selection for malignant melanoma.

e22027Background: Genomic profiling informs clinical decision-making for malignant melanoma (MM) as specific tumor mutations can be treated with targeted therapy (TT). However, given the range of d...